Fluorescent gelatin degradation assay indicates that suppression of BST-2 significantly reduced the area of gelatin proteolysis by 4T1 breast cancer cells as indicated by the loss of fluorescent signal (Fig. 5A,B). Here, BST2 is linked to breast carcinoma.